Non-Small Cell Lung Cancer New Indication: Perioperative Nivolumab and Chemotherapy for Stage III NSCLC Ulas D. Bayraktar, MD 2023-08-20
Soft Tissue Sarcoma New Protocol: Nivolumab and Trabectedin in Advanced Soft Tissue Sarcoma Ulas D. Bayraktar, MD 2023-06-24
GastroEsophageal Cancer New Protocol: First-line regorafenib with nivolumab and chemotherapy in advanced esophageal, gastric, or gastro-esophageal junction cancer Ulas D. Bayraktar, MD 2023-06-07
Non-Small Cell Lung Cancer New Indication: Neoadjuvant Nivolumab for NSCLC Ulas D. Bayraktar, MD 2022-09-20
